Northwestern Mutual Wealth Management
DNA icon

Northwestern Mutual Wealth Management’s Ginkgo Bioworks DNA Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.64K Buy
757
+1
+0.1% +$8 ﹤0.01% 3340
2025
Q4 		$6.28K Sell
756
-45
-6% -$485 ﹤0.01% 3146
2025
Q3 		$11.7K Buy
801
+178
+29% +$2.13K ﹤0.01% 2853
2025
Q2 		$7.01K Hold
623
– – ﹤0.01% 2911
2025
Q1 		$3.55K Hold
623
– – ﹤0.01% 3025
2024
Q4 		$6.12K Buy
623
+25
+4% +$214 ﹤0.01% 2896
2024
Q3 		$4.87K Sell
598
-4
-0.7% -$40 ﹤0.01% 2910
2024
Q2 		$8.04K Buy
602
+250
+71% +$7.46K ﹤0.01% 2723
2024
Q1 		$16.3K Sell
352
-12
-3% -$621 ﹤0.01% 2475
2023
Q4 		$24.6K Sell
364
-44
-11% -$2.69K ﹤0.01% 2331
2023
Q3 		$29.6K Buy
408
+132
+48% +$10.6K ﹤0.01% 2172
2023
Q2 		$20.5K Buy
+276
New +$16.3K ﹤0.01% 2303
2023
Q1 		– Hold
0
– -$8 – 3412
2022
Q4 		– Hold
0
– – – 3297
2022
Q3 		– Hold
0
– – – 3177
2022
Q2 		– Hold
0
– – – 3237

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northwestern Mutual Wealth Management's DNA Position: Q1 2026 in Review

Northwestern Mutual Wealth Management increased its Ginkgo Bioworks (DNA) stake by 0.13% in Q1 2026, buying an estimated $8 and bringing the position to 757 shares worth $4.64K. The position accounts for ﹤0.01% of the portfolio, ranked #3340.

Northwestern Mutual Wealth Management first reported a position in DNA in Q2 2023 and has held it in 12 quarters since. The position peaked at $29.6K in Q3 2023. 175 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Northwestern Mutual Wealth Management held 757 shares of Ginkgo Bioworks worth $4.64K as of Q1 2026.
  • Northwestern Mutual Wealth Management bought 1 Ginkgo Bioworks share in Q1 2026, an estimated $8.
  • Ginkgo Bioworks made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3340 holding.
  • Northwestern Mutual Wealth Management first reported a position in Ginkgo Bioworks in Q2 2023 and has held it in 12 quarters since.
  • Northwestern Mutual Wealth Management's Ginkgo Bioworks position peaked at $29.6K in Q3 2023.
  • 175 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.